Ardelyx appoints Sue Hohenleitner as CFO

ARDELYX, INC.

Appointed Sue Hohenleitner as CFO effective Nov 4, 2025; she joins Oct 13, 2025.
Hohenleitner previously VP & CFO of J&J Innovative Medicine NA ($36B business).
Annual base salary $550,000, target bonus 45% of base, sign-on bonus $180,000.
Received option to purchase 578,104 shares at $5.01/share and 146,896 RSUs, four-year vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.